Neoadjuvant SBRT in Localized Advanced HNSCC

NCT06306846 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Carcinoma

Interventions

RADIATION: SBRT+immunochemotherpy
DRUG: Immunochemotherapy
DRUG: cetuximab+immunochemotharpy

Sponsor

Jiang Feng